AstraZeneca Revamps NYSE Listing To Woo US Investors
Pharmaceutical heavyweight AstraZeneca PLC said on Monday that it is overhauling its New York listing in an effort to attract U.S. investors but will retain its primary listing and headquarters in...To view the full article, register now.
Already a subscriber? Click here to view full article